Fulgent Genetics, Inc. (NASDAQ:FLGT) is seeing a significant increase in short-term interest

Fulgent Genetics, Inc. (Nasdaq: FLGT – Get the rating) received a large increase in short interest during the month of January. As of January 15, there was short interest totaling 1,170,000 shares, an increase of 14.7% from the December 31 total of 1,020,000 shares. Based on average daily trading volume, of 274,400 shares, the short … Read more

Editas Medicine, Inc. (NASDAQ:EDIT) was given an average rating of “Hold” by analysts

Shares of Editas Medicine, Inc. (Nasdaq: Edit – Get the rating) have received an average rating of “Hold” by fourteen brokerage firms covering the firm, MarketBeat Reviews reports. Three equity research analysts rated the stock with a sell rating, seven gave a hold rating and three assigned a buy rating to the company. The average … Read more